The OSUCCC Transgenic Animal Shared Resource (TASR) provides support in the areas of transgenic and embryonic stem cell technologies through two state-of-the-art facilities located at the OSU Neurobiotechnology Center and at Columbus Children's Hospital (CCH). These facilities meet the needs of the OSUCCC investigators whose laboratories are spread over an area of five miles. The facilities provide services in the generation of transgenic and gene targeted mouse strains, including """"""""knock-out"""""""" and """"""""knock-in"""""""" mouse models for OSUCCC investigators located in different areas of the campus including, The Neurobiotechnology Center, CCH, College of Medicine and Public Health, College of Biological Sciences and College of Veterinary Medicine. The TASR provides common basic services such as pro- nuclear and blastocyst injections, cryopreservation technology, training opportunities in embryonic stem cell techniques and maintenance of unique mouse models for OSUCCC investigators. The facilities are equipped with resources including four inverted microscopes with micromanipulators for microinjection, microforges, micropipette pullers, C02 incubators and refrigerators/freezers. In addition tot he in-house generated mouse strains, the facilities also house multiple mutant strains of mice for onsite access to the investigators. Training in ES/Transgenic technology provided to CCC members at various levels includes hands-on training and organized lectures and workshops. Pappachan Kolattukudy, Ph.D. is the director and Natarajan Muthasamy, D.V.M., Ph.D., is the co- director of the facilities. Michael Robinson, Ph.D. and Jan Parker- Thornburg, Ph.D. provide the transgenic services, while Drs. Muthasamy and Bedrich Mosinger, M.D., Ph.D. provide services in embryonic stem cell technologies. These individuals provide consultation to CCC members for generation of transgenic and targeting constructs, gene targeting in embryonic stem cell technology and generation of induced mutant mouse resources. In addition, the personnel of the OSUCCC TASR organized workshops, develop protocols, and provide assistance with analyses of genetically engineered mice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-26
Application #
6430843
Study Section
Project Start
2001-03-07
Project End
2001-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Lampis, Andrea; Carotenuto, Pietro; Vlachogiannis, Georgios et al. (2018) MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma. Gastroenterology 154:1066-1079.e5
Le Gallo, Matthieu; Rudd, Meghan L; Urick, Mary Ellen et al. (2018) The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas. Cancer 124:65-73
Jones, Jeffrey A; Mato, Anthony R; Wierda, William G et al. (2018) Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol 19:65-75
Baldassari, Federica; Zerbinati, Carlotta; Galasso, Marco et al. (2018) Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors. Front Genet 9:174
Yang, Xiaosong; Pan, You; Qiu, Zhaojun et al. (2018) RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells. Clin Cancer Res 24:1629-1643
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Ngankeu, Apollinaire; Ranganathan, Parvathi; Havelange, Violaine et al. (2018) Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia. Oncotarget 9:4354-4365
Lopez, Cecilia M; Yu, Peter Y; Zhang, Xiaoli et al. (2018) MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines. PLoS One 13:e0190086
Victor, Aaron R; Weigel, Christoph; Scoville, Steven D et al. (2018) Epigenetic and Posttranscriptional Regulation of CD16 Expression during Human NK Cell Development. J Immunol 200:565-572
Hankey, William; Chen, Zhong; Bergman, Maxwell J et al. (2018) Chromatin-associated APC regulates gene expression in collaboration with canonical WNT signaling and AP-1. Oncotarget 9:31214-31230

Showing the most recent 10 out of 2602 publications